Acute and recovery phase of cerebral infarction (e.g., ischemia due to stroke).
Cognitive dysfunction due to degenerative (i.e., Alzheimer's disease) and cerebrovascular disease.
Cerebral insufficiency (e.g., dizziness, memory loss, poor concentration, disorientation) due to head trauma or brain injury.
1-2 tablets, once daily, preferably after meals. Or as prescribed by the physician.
1 g injection as recommended by the physician.
Administration: For ORAL drugs only. With or without food.
Hypersensitivity to any component of the product.
Patient with hypertonia of the parasympathetic nervous system.
Large dose of citicoline could aggravate increase in cerebral blood flow in episodes of persistent intracranial hemorrhage.
Use in Children: No data on use in children.
There is not enough evidence on citicoline's safety in pregnant and breastfeeding women. Citicoline should be used in pregnancy and breastfeeding only when benefits justify the potential risks.
Citicoline must not be administered with products containing meclofexonate.
Citicoline potentiates the effect of L-dopa.
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and nootropics.
Tab 500 mg x 30's. Inj 1,000 mg (amp) x 4 mL x 6's.